logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10392604 B1

PDFFull Text
Date of Patent:
Aug. 27, 2019

Filed:

Nov. 03, 2016

Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases

Applicant:

Pharmenterprises Biotech Limited Liability Company, Moscow, RU;

Inventors:

Andrei Yurievich Egorov, St. Petersburg, RU;

Boris Ferko, Vienna, AT;

Artem Alexandrovich Krokhin, The Crimea, RU;

Yulia Romanovna Romanova, St. Petersburg, RU;

Assignee:

PHARMENTERPRISES BIOTECH Limited Liability Company, Moscow, RU;

Attorney:

Morrison & Foerster LLP

Primary Examiner:

Rachel B Gill

Int. Cl.
CPC ...
C12N 7/00 (2006.01); A61K 35/76 (2015.01); A61K 39/00 (2006.01); A61K 39/12 (2006.01); A61P 31/16 (2006.01); C12N 15/86 (2006.01); A61K 39/145 (2006.01); C07K 14/005 (2006.01);
U.S. Cl.
CPC ...
C12N 7/00 (2013.01); A61K 35/76 (2013.01); A61K 39/12 (2013.01); A61K 39/145 (2013.01); A61P 31/16 (2018.01); C07K 14/005 (2013.01); C12N 15/86 (2013.01); A61K 2039/5254 (2013.01); C12N 2760/16121 (2013.01); C12N 2760/16122 (2013.01); C12N 2760/16143 (2013.01); C12N 2760/16162 (2013.01); C12N 2760/16171 (2013.01);
Abstract

The present invention relates to the field of medicine and virology. An attenuated influenza A virus, an influenza virus vector based thereon, and a pharmaceutical composition comprising thereof are provided, which can be used for the prevention and/or treatment of an infectious disease. In addition, the present invention relates to an attenuated influenza A virus, an influenza virus vector based thereon, and a pharmaceutical composition comprising thereof, which can be used for the treatment of oncological diseases.

Find Patent Forward Citations

Loading…